BEIJING, Sept. 26, 2011 /PRNewswire-Asia-FirstCall/ China
Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the
"Company"), one of the leading plasma-based biopharmaceutical
companies in the People's Republic of
China, today announced that it will participate in the
Jefferies 2011 Global Healthcare Conference on September 27 and 28, 2011 in London, UK.
Mr. Ming Yin, China Biologic's
Vice President of Finance, will present at the conference on
Wednesday, September 28 at
5:00pm.
Investors interested in meeting with China Biologic during the
conference should please contact their Jefferies
representative.
About China Biologic Products, Inc.
China Biologic Products, Inc., through its indirect
majority-owned subsidiaries, Shandong Taibang Biological Products
Co., Ltd. and Guizhou Taibang Biological Co., and its equity
investment in Xi'an Huitian Blood Products Co., Ltd., is one of the
leading plasma-based biopharmaceutical companies in China. The Company is a fully integrated
biologic products company with plasma collection, production and
manufacturing, research and development, and commercial operations.
The Company's plasma-based biopharmaceutical products are
irreplaceable during medical emergencies and are used for the
prevention and treatment of various diseases. The Company sells its
products to hospitals and other healthcare facilities in
China. Please see the Company's
website at www.chinabiologic.com for additional information.
Company contact:
Mr. Y. Tristan Kuo
Chief Financial Officer
China Biologic Products, Inc.
Telephone: +86 53 8620 2206
Email: IR@chinabiologic.com
SOURCE China Biologic Products, Inc.